Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Vlacich G, Samson PP, Perkins SM, et al. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer database [J]. Cancer Med. 2017;6(12):2886–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pilleron S, Sarfati D, Janssen-Heijnen M, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study [J]. Int J Cancer. 2019;144(1):49–58.

Article  CAS  PubMed  Google Scholar 

Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85 – 01). Radiation Therapy Oncol Group [J] Jama. 1999;281(17):1623–7.

CAS  Google Scholar 

Kamarajah SK, Gujjuri RR, Elhadi M, et al. Elderly patients have increased perioperative morbidity and mortality from oesophagectomy for oesophageal cancer: a systematic review and meta-analysis [J]. Eur J Surg Oncol. 2021;47(8):1828–35.

Article  PubMed  Google Scholar 

Wakui R, Yamashita H, Okuma K, et al. Esophageal cancer: definitive chemoradiotherapy for elderly patients [J]. Dis Esophagus. 2010;23(7):572–9.

Article  CAS  PubMed  Google Scholar 

Ai D, Ye J, Wei S, et al. Comparison of 3 paclitaxel-based chemoradiotherapy regimens for patients with locally advanced esophageal squamous cell Cancer: a randomized clinical trial [J]. JAMA Netw Open. 2022;5(2):e220120.

Article  PubMed  PubMed Central  Google Scholar 

Walter F, Böckle D, Schmidt-Hegemann NS, et al. Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis [J]. Radiat Oncol. 2018;13(1):93.

Article  PubMed  PubMed Central  Google Scholar 

Liu LH, Yan MH, Di YP, et al. Comparison of involved-field intensity-modulated radiotherapy combined with S-1 vs radiotherapy alone for elderly patients with esophageal cancer [J]. World J Clin Cases. 2022;10(21):7365–75.

Article  PubMed  PubMed Central  Google Scholar 

Huang J, Cao Y, Wu L, et al. S-1-based therapy versus 5-FU-based therapy in advanced gastric cancer: a meta-analysis [J]. Med Oncol. 2011;28(4):1004–11.

Article  CAS  PubMed  Google Scholar 

Pilleron S, Soto-Perez-de-Celis E, Vignat J, et al. Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050 [J]. Int J Cancer. 2021;148(3):601–8.

Article  CAS  PubMed  Google Scholar 

Moretto F, Rampino M, Munoz F, et al. Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment [J]. Radiol Med. 2014;119(8):634–41.

Article  PubMed  Google Scholar 

Lee Y, Samarasinghe Y, Lee MH, et al. Role of adjuvant therapy in Esophageal Cancer patients after Neoadjuvant Therapy and Esophagectomy: a systematic review and Meta-analysis [J]. Ann Surg. 2022;275(1):91–8.

Article  PubMed  Google Scholar 

Yamashita H, Okuma K, Wakui R, et al. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma–a retrospective analysis [J]. Radiother Oncol. 2011;98(2):255–60.

Article  PubMed  Google Scholar 

Kato K, Nakajima TE, Ito Y, et al. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 gy with elective nodal irradiation for stage II-III esophageal carcinoma [J]. Jpn J Clin Oncol. 2013;43(6):608–15.

Article  PubMed  Google Scholar 

Chen Y, Zhu Z, Zhao W, et al. Long-term results of a phase 2 study of definitive chemoradiation therapy using S-1 for esophageal squamous cell carcinoma patients who were Elderly or with Serious comorbidities [J]. Front Oncol. 2022;12:839765.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen SB, Huang SJ, Liu DT et al. Clinicopathological features and prognosis of esophageal squamous cell carcinoma in young patients [J]. Dis Esophagus, 2019, 32(5).

Wang H, Li G, Chen L, et al. Definitive concurrent chemoradiotherapy with S-1 and cisplatin in elderly esophageal squamous cell carcinoma patients [J]. J Thorac Dis. 2017;9(3):646–54.

Article  PubMed  PubMed Central  Google Scholar 

Anderson SE, Minsky BD, Bains M, et al. Combined modality chemoradiation in elderly oesophageal cancer patients [J]. Br J Cancer. 2007;96(12):1823–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xing L, Liang Y, Zhang J, et al. Definitive chemoradiotherapy with capecitabine and cisplatin for elder patients with locally advanced squamous cell esophageal cancer [J]. J Cancer Res Clin Oncol. 2014;140(5):867–72.

Article  CAS  PubMed  Google Scholar 

Huang C, Zhu Y, Li Q, et al. Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: experience of two centers [J]. Cancer Med. 2019;8(1):28–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hulshof M, Geijsen ED, Rozema T, et al. Randomized study on dose escalation in definitive chemoradiation for patients with locally Advanced Esophageal Cancer (ARTDECO Study) [J]. J Clin Oncol. 2021;39(25):2816–24.

Article  CAS  PubMed  Google Scholar 

Jia R, Shan T, Zheng A et al. Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in definitive concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma (CRTCOESC): a Multicenter, Randomized, Open-Label, phase 3 trial [J]. J Clin Oncol, 2024: Jco2302009.

Huang C, Huang D, Zhu Y, et al. Comparison of a concurrent fluorouracil-based regimen and a taxane-based Regimen combined with Radiotherapy in Elderly patients with esophageal squamous cell carcinoma [J]. Transl Oncol. 2020;13(3):100736.

Article  PubMed  PubMed Central  Google Scholar 

Wu J, Lu AD, Zhang LP, et al. [Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia] [J]. Zhonghua Xue Ye Xue Za Zhi. 2019;40(1):52–7.

CAS  PubMed  Google Scholar 

Satoh T, Sakata Y. S-1 for the treatment of gastrointestinal cancer [J]. Expert Opin Pharmacother. 2012;13(13):1943–59.

Article  CAS  PubMed  Google Scholar 

Song GM, Tian X, Liu XL, et al. Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis [J]. Oncotarget. 2017;8(23):37963–73.

Article  PubMed  PubMed Central  Google Scholar 

Xu Y, Dong B, Zhu W, et al. A phase III Multicenter Randomized Clinical Trial of 60 gy versus 50 gy Radiation Dose in Concurrent Chemoradiotherapy for inoperable esophageal squamous cell carcinoma [J]. Clin Cancer Res. 2022;28(9):1792–9.

Article  CAS  PubMed  Google Scholar 

Okamoto I, Fukuoka M. S-1: a new oral fluoropyrimidine in the treatment of patients with advanced non-small-cell lung cancer [J]. Clin Lung Cancer. 2009;10(4):290–4.

Article  CAS  PubMed  Google Scholar 

Wang X, Han W, Zhang W, et al. Effectiveness of S-1-Based chemoradiotherapy in patients 70 years and older with esophageal squamous cell carcinoma: a randomized clinical trial [J]. JAMA Netw Open. 2023;6(5):e2312625.

Article  PubMed  PubMed Central  Google Scholar 

Zhou R, Luo G, Guo S, et al. Moderately hypo-fractionated radiotherapy combined with S-1 in inoperable locally advanced esophageal squamous cell carcinoma: a prospective, single-arm phase II study (GASTO-1045) [J]. Front Oncol. 2023;13:1138304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar S, Dimri K, Khurana R, et al. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus [J]. Radiother Oncol. 2007;83(2):139–47.

Article  C